Search

Bio Roundup: Moderna's IPO, Arena's Comeback, E-Cig Survey & More

BIO ROUNDUP: MODERNA'S IPO, ARENA'S COMEBACK, E-CIG SURVEY & MORE

Thanksgiving is around the corner and this week delivered a bounty of deals that have a number of life science companies expressing...

10 Herbs & Superfoods with Cannabinoids Similar to Cannabis

10 HERBS & SUPERFOODS WITH CANNABINOIDS SIMILAR TO CANNABIS

It's a hot topic in the news and among our law makers today - controversial cannabis oil and its therapeutic value. We know that cannabinoids,...

 
 
 
Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact

CELGENE DOUBLES DOWN ON DRAGONFLY, PAYS $50M TO EXPAND CANCER PACT

Celgene's collaboration with Dragonfly Therapeutics is less than 18 months old, but the pharmaceutical company is already expanding...

 
 
 

TECHNICIAN; BUFFER MEDIA AND LAB SUPPORT - PFENEX INC. - SAN DIEGO, CA

Pfenex is a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value, difficult to...

 
 
 

VIKING THERAPEUTICS PRESENTS RESULTS FROM PHASE 2 STUDY OF VK2809 IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ELEVATED LDL-CHOLESTEROL IN ORAL LATE-BREAKER PRESENTATION AT THE LIVER MEETING® 2018

Study Achieves Primary Endpoint, Demonstrating Statistically Significant LDL-C Reductions in Patients Receiving VK2809 at Week 1267%...

HARPOON RAISES $70M TO TRIAL SOLID TUMOR T-CELL ENGAGERS

Harpoon Therapeutics has raised $70 million to advance its pipeline of T-cell engagers. The series C sets Harpoon up to move candidates...

 
 
 

BOEHRINGER POWERS CANCER VACCINE STARTUP AMAL TO B ROUND

Amal Therapeutics has added €21.2 million to its series B round. Boehringer Ingelheim Venture Fund co-led the financing to tee Amal...

FDA commissioner highlights efforts to improve expanded access program

FDA COMMISSIONER HIGHLIGHTS EFFORTS TO IMPROVE EXPANDED ACCESS PROGRAM

The agency also launched in information website about Right to Try, which President Donald Trump signed into law in May.

 
 
 
The president of the company headed for the biggest IPO in biotech history has a surprisingly large pay package

THE PRESIDENT OF THE COMPANY HEADED FOR THE BIGGEST IPO IN BIOTECH HISTORY HAS A SURPRISINGLY LARGE PAY PACKAGE

Moderna Therapeutics, a buzzy startup with a $7 billion private valuation , filed paperwork on Friday to go public. According to a...

BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act

BIO CELEBRATES 300 BIOTECH IPOS SINCE ENACTMENT OF THE JOBS ACT

The biotech industry recently realized its 300 th IPO since the Jumpstart Our Business Startups Act was enacted in 2012. This marks...

 
 
 
Singing may reduce blood pressure and stress levels in people with Parkinson's disease, study says

SINGING MAY REDUCE BLOOD PRESSURE AND STRESS LEVELS IN PEOPLE WITH PARKINSON'S DISEASE, STUDY SAYS

A new study from Iowa State University has found that singing reduced heart rate, blood pressure and cortisol levels in Parkinson's...

 
 
 
 
 
 
With FDA Panel's Nod, First Postpartum Depression Drug Nears Approval

WITH FDA PANEL'S NOD, FIRST POSTPARTUM DEPRESSION DRUG NEARS APPROVAL

A panel of experts on Friday voted in favor of bringing what could be the first-ever drug approved specifically for postpartum depression...

Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs

SANOFI PLEDGES $125M TO DENALI IN PACT FOR NEURO, INFLAMMATION DRUGS

Sanofi sees potential in two early-stage Denali Therapeutics drugs as a way to reduce inflammation in the brain and throughout the...

 
 
 
Opportunities for Patient and Health Advocates

OPPORTUNITIES FOR PATIENT AND HEALTH ADVOCATES

Last week, the seventh annual Patient and Health Advocacy Summit brought hundreds of patient advocates, industry experts and policymakers...

CIRIUS THERAPEUTICS REPORTS POSITIVE MIDSTAGE RESULTS FOR LIVER DISEASE DRUG

Cirius Therapeutics said its flagship liver disease drug has shown positive interim results in a midstage clinical trial. The drug...